MK-2248

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-2248, covering 2015-06-08 to 2015-06-08. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Pharmacokinetics, and Pharmacodynamics of MK-2248 in Participants With Hepatitis C (MK-2248-002) [Phase 1]

See pricing